/biz/ - Business & Finance

>The WOMAC pain scores constituting the study’s primary endpoint showed 44% improvement from baseline at day 14 for the 200 and 250 mg once-daily doses, and 39% for the 150 mg once-daily dose. NSAIDs typically reach their maximum effectiveness after 6-8 weeks of administration and remain at that level while treatment continues. ATB-346 produced significant decreases in pain within 2 weeks of treatment. All three doses of ATB-346 reflect well in light of results from a recent peer-reviewed meta-analysis of historical NSAID osteoarthritis pain trials from Harvard researchers
>Supplementing the WOMAC results are the secondary data of cyclo-oxygenase (“COX”) enzyme inhibition. NSAIDs reduce pain and inflammation by inhibiting the activity of COX enzymes. ATB-346 exhibited profound inhibition of COX (all doses yielding >90% inhibition) with a very high degree of statistical significance, and with negligible difference observed across the three doses. This is exceptionally strong data that is consistent with self-assessment of pain by the patients.
>Trial participants treated with ATB-346 experienced neither an increase nor decrease in blood pressure in contrast with other NSAIDs, which often increase blood pressure. Blood pressure increases are viewed by medical practitioners globally as being an important proxy for the cardiovascular risk of NSAIDs. The absence of an increase in blood pressure has been a consistent finding in all of ATB-346’s clinical trials to-date and suggests a favourable cardiovascular safety profile for the drug.

ITOLIZUMAB, PSORIASIS DRUG CUTS DEATH RISK FOR COVID PATIENTS: STUDY

so let me get this straight, tomorrow we want to be all in on
>horse
>blnk
>shll
what else

>Printers: running
>Buffet: retarded
>Oil storage: at capacity
>Soros: out of touch
>Debt load: doesn't matter
>Major cities: burning and looted
Oh yeah, it's mumu time.

>>19393111
checked